Core Viewpoint - The report from CITIC Securities indicates that despite external environmental changes and internal structural adjustments, China's macro economy is expected to maintain a steady recovery in 2026, supported by policy measures. Group 1: Economic Trends - Trend 1: Domestic demand recovery is anticipated to drive overall growth [1] - Trend 2: Investment is expected to shift from total pressure to structural optimization [1] - Trend 3: Sino-US relations are likely to ease, with no significant escalation of major frictions expected in 2026 [1] Group 2: Market Outlook - Trend 4: The acceleration of market diversification is projected, with external demand prospects in 2026 expected to be better than in 2025 [1] - Trend 5: As the first year of the 14th Five-Year Plan, it is expected that counter-cyclical and cross-cyclical adjustments will be strengthened [1]

Core Viewpoint - The technology and processes for natural collagen and recombinant collagen are continuously improving, leading to an expansion of application scenarios and an increase in the number of approved collagen products, which will enrich indications and enhance market penetration [1] Industry Summary - The number of registered certificates for natural collagen and recombinant collagen products is increasing but is still far from saturation, providing opportunities for various companies to share in the industry's growth [1] - The medical beauty market is expected to see an increase in both the number of consumers and market penetration as more collagen products are approved [1] Company Recommendations - The recombinant collagen freeze-dried fiber registration certificate is expected to be approved and launched in the first half of 2026, with recombinant collagen solutions and gels also anticipated to receive approval in 2026, potentially becoming a second growth curve for companies [1] - Companies entering the natural collagen field through acquisitions, with steady progress in the research and clinical development of related medical beauty Class III devices, are expected to gain approval in the future and become new forces in the existing medical beauty biomaterials matrix [1] - Companies with strong drug development and review experience that are simultaneously laying out natural and recombinant collagen through agency and self-research are well-positioned for growth [1]

中信证券研报表示，铁锂行业盈利有望迎来周期性的拐点。需求端，动力领域铁锂渗透率的进一步提升 以及储能的高景气度带来需求的快速增长，我们测算2026年全球磷酸铁锂正极材料出货量有望达到525 万吨，同比+36%；供给端，我们预计2026年增长有限，整体稼动率有望进一步提升，其中高端品仍较 为紧缺。当前铁锂盈利能力处于周期底部，伴随供需结构改善有望迎来修复空间，产品高端化、出海趋 势的进一步明确有望为头部企业带来超额利润。重点推荐铁锂行业内头部企业。 ...

Group 1 - The recent appreciation of the RMB is favorable for the performance of RMB-denominated equity assets [1] - The central bank will adopt more flexible policy tools in the next phase, with a focus on domestic demand targets [1] - By 2026, stable macro-financial conditions are expected to indicate a stable banking operating environment, with bank interest margins reaching a bottom and a recovery in income and profitability for the real sector [1] Group 2 - The absolute return logic for the banking sector comes from the re-evaluation of systemic risks, leading to valuation recovery [1] - The stable characteristics of equity returns are expected to drive capital inflows into the sector [1] - It is anticipated that the sector will continue to experience valuation enhancement trends in 2026 [1]

中信证券研报称，铁锂行业盈利有望迎来周期性的拐点。需求端，动力领域铁锂渗透率的进一步提升以 及储能的高景气度带来需求的快速增长，我们测算2026年全球磷酸铁锂正极材料出货量有望达到525万 吨，同比+36%；供给端，我们预计2026年增长有限，整体稼动率有望进一步提升，其中高端品仍较为 紧缺。当前铁锂盈利能力处于周期底部，伴随供需结构改善有望迎来修复空间，产品高端化、出海趋势 的进一步明确有望为头部企业带来超额利润。重点推荐铁锂行业内头部企业。 ...

中信证券研报称，受益政策、技术和市场三维驱动，商业航天迎来景气高企。在太空算力需求拉动下， 火箭、卫星结构轻量化以及特殊应用环境对于碳纤维材料提出更高要求，石墨纤维凭借耐高温、高强高 模以及低热膨胀系数等优势，渗透率有望进一步提升。我们预计伴随着下游需求放量，在国产化驱动 下，布局石墨纤维的相关企业有望充分受益。 ...

Core Viewpoint - The article discusses the challenges faced by Guangtai Vacuum Technology Co., Ltd. in its application for listing on the Beijing Stock Exchange, highlighting the company's unique market position and the involvement of CITIC Securities as both a sponsor and investor [2][18]. Company Overview - Guangtai Vacuum is a high-tech enterprise focused on the research, development, manufacturing, and sales of vacuum equipment, particularly in the rare earth permanent magnet industry [4]. - The company aims to raise 168 million yuan by issuing up to 17 million shares for the expansion of its vacuum melting furnace and sintering furnace production, as well as the construction of a research and product display center [5]. Listing Application Process - Guangtai Vacuum submitted its listing application on June 23, 2025, and received acceptance after a swift process, completing the entire listing guidance in just three months [5][6]. - The company became the third entity sponsored by CITIC Securities to gain the opportunity for review by the listing committee in 2025 [8]. Challenges in Listing Approval - The listing application was deferred due to concerns from the listing committee regarding the accuracy of revenue recognition and the sustainability of the company's performance [11][12]. - Guangtai Vacuum's revenue growth showed a significant increase in 2023, but signs of fatigue were evident in 2024, raising questions about the sustainability of its performance [11]. Revenue Recognition Issues - The company’s revenue recognition method, which requires installation and acceptance by customers, has led to delays in revenue confirmation, with some projects taking over 15 months for acceptance [15][16]. - The listing committee requested further clarification on contracts and revenue recognition practices to address these concerns [16]. CITIC Securities' Role - CITIC Securities is utilizing a "sponsorship + direct investment" model for the first time in the Beijing Stock Exchange, which allows them to potentially gain equity premium in addition to sponsorship fees [18][19]. - This model is seen as a way to enhance the participation of securities firms in smaller projects on the Beijing Stock Exchange, thereby supporting financing for small and medium-sized enterprises [20].

Core Insights - The A-share private placement market is experiencing a significant recovery, with 155 listed companies raising a total of 824.45 billion yuan in 2025, nearly quadrupling the 206.65 billion yuan raised in 2024 and surpassing the 780.45 billion yuan raised in 2022 [1][5][11] Group 1: Market Recovery - The surge in fundraising is attributed to multiple favorable factors, including a stable market since September 2024, improved market capacity, and a shift towards more lenient refinancing policies [7][8][9] - The completion rate for fundraising in 2025 reached 98.81%, a significant increase of 12.25 percentage points compared to 2024, indicating strong market support for quality projects [5][6][11] Group 2: Underwriting Landscape - The total underwriting amount for private placements by securities firms in 2025 soared to 716.89 billion yuan, more than five times the 140.57 billion yuan in 2024 [11][12] - CITIC Securities led the underwriting market with 188.56 billion yuan, followed by Guotai Junan and Bank of China, which ranked second and third respectively [11][12] - Despite the increase in underwriting amounts, the total revenue from underwriting activities only slightly rose to 1.05 billion yuan, reflecting intense competition in the industry [11][12]

Core Viewpoint - The A-share private placement market is experiencing a significant recovery, with fundraising in 2025 reaching 824.45 billion yuan, nearly quadrupling from 206.65 billion yuan in 2024, and surpassing 780.45 billion yuan in 2022, signaling a rebound in market confidence [1][2][3]. Fundraising Overview - As of December 29, 2025, 155 listed companies have raised a total of 824.45 billion yuan through private placements, marking a substantial increase compared to previous years [2][3]. - The fundraising completion rate for 2025 stands at 98.81%, a notable improvement of 12.25 percentage points from 2024, indicating strong market support for quality projects [3][4]. Market Dynamics - The recovery in the A-share market since September 2024 has enhanced the capacity for absorbing refinancing funds, leading to a decrease in the difficulty of project issuance [4]. - A shift towards a more lenient regulatory environment and faster review processes by exchanges has facilitated smoother approvals for private placements [4]. - The backlog of financing needs from 2023 and 2024 has been released, prompting many companies to seize the opportunity to launch refinancing projects [4]. Underwriting Landscape - The total underwriting amount for private placements by securities firms surged to 716.89 billion yuan in 2025, more than five times that of 2024 [6]. - CITIC Securities led the underwriting with 188.56 billion yuan, followed by Guotai Junan and Bank of China Securities, which ranked second and third, respectively [6][7]. - The increase in underwriting amounts does not correspond to a significant rise in industry revenue, which only slightly increased to 1.05 billion yuan in 2025 [8]. Competitive Factors - Bank of China Securities achieved a high ranking in underwriting due to securing large-scale projects from major banks, contributing significantly to its total [7]. - CITIC Securities dominated the market by being the lead underwriter for all four major private placements exceeding 100 billion yuan in 2025 [7].

用友网络科技股份有限公司向港交所提交上市申请书，联席保荐人为招银国际、中信证券。 ...